Pemetrexed
- Product NDC
- 25021-260
- 11-digit product format
- 250210260
- Labeler code
- 25021
- Product ID
- 25021-260_f9386c39-eee1-4407-91b7-f55bc710897a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pemetrexed Disodium
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA204890
- Marketing category
- ANDA
- Marketing start
- 2024-12-15
- Substance
- PEMETREXED DISODIUM HEMIPENTAHYDRATE
- Active strength
- 100 mg/4.2mL
- Pharmacologic classes
- Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| F4GSH45R4C | PEMETREXED DISODIUM HEMIPENTAHYDRATE | 357166-30-4 | PEMETREXED DISODIUM HEMIPENTAHYDRATE |
| 2PKU919BA9 | PEMETREXED DISODIUM | 150399-23-8 | Pemetrexed Disodium |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 25021-260-10 | 25021026010 | 1 VIAL in 1 CARTON (25021-260-10) / 4.2 mL in 1 VIAL | 1 vial | 2024-12-15 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Pemetrexed | Sagent Pharmaceuticals | 2024-09-30 | HUMAN PRESCRIPTION DRUG LABEL | 1 |